{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:39:05Z","timestamp":1790285945352,"version":"4.1.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"am","delay-in-days":326,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL151367"],"award-info":[{"award-number":["HL151367"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.thromres.2022.08.015","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T23:26:07Z","timestamp":1660865167000},"page":"72-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Challenging clinical scenarios for therapeutic anticoagulation: A practical approach"],"prefix":"10.1016","volume":"218","author":[{"given":"Kylee L.","family":"Martens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone E.","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"DeLoughery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Shatzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.thromres.2022.08.015_bb0005","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/s-0038-1676611","article-title":"Characteristics and management of patients with venous thromboembolism: the GARFIELD-VTE registry","volume":"119","author":"Ageno","year":"2019","journal-title":"Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.thromres.2022.08.015_bb0010","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1160\/TH16-10-0823","article-title":"Venous thromboembolism: past, present and future","volume":"117","author":"Schulman","year":"2017","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.08.015_bb0015","series-title":"StatPearls","article-title":"Virchow Triad","author":"Kushner","year":"2021"},{"issue":"6","key":"10.1016\/j.thromres.2022.08.015_bb0020","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.thromres.2022.08.015_bb0025","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"Khorana","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.thromres.2022.08.015_bb0030","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ajh.25494","article-title":"Bleeding incidence and risk factors among cancer patients treated with anticoagulation","volume":"94","author":"Angelini","year":"2019","journal-title":"Am. J. Hematol."},{"issue":"7","key":"10.1016\/j.thromres.2022.08.015_bb0035","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1111\/crj.12795","article-title":"Comparative efficacy and safety of low-intensity warfarin therapy in preventing unprovoked recurrent venous thromboembolism: a systematic review and meta-analysis","volume":"12","author":"Jiang","year":"2018","journal-title":"Clin. Respir. J."},{"issue":"5","key":"10.1016\/j.thromres.2022.08.015_bb0040","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update","volume":"38","author":"Key","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.thromres.2022.08.015_bb0045","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv."},{"issue":"10","key":"10.1016\/j.thromres.2022.08.015_bb0050","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1111\/jth.14564","article-title":"The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: guidance from the SSC of the ISTH","volume":"17","author":"Wang","year":"2019","journal-title":"J. Thromb. Haemost."},{"issue":"13","key":"10.1016\/j.thromres.2022.08.015_bb0055","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMoa1700518","article-title":"Rivaroxaban or aspirin for extended treatment of venous thromboembolism","volume":"376","author":"Weitz","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.thromres.2022.08.015_bb0060","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"Agnelli","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.thromres.2022.08.015_bb0065","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM199802123380701","article-title":"A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Pr\u00e9vention du Risque d'Embolie Pulmonaire par interruption Cave Study Group","volume":"338","author":"Decousus","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.thromres.2022.08.015_bb0070","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1001\/jama.2015.3780","article-title":"Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial","volume":"313","author":"Mismetti","year":"2015","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.thromres.2022.08.015_bb0075","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1056\/NEJMoa1806515","article-title":"A multicenter trial of vena cava filters in severely injured patients","volume":"381","author":"Ho","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.thromres.2022.08.015_bb0080","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jamainternmed.2013.343","article-title":"Indications, complications, and management of inferior vena cava filters: the experience in 952 patients at an academic hospital with a level I trauma center","volume":"173","author":"Sarosiek","year":"2013","journal-title":"JAMA Intern. Med."},{"issue":"4","key":"10.1016\/j.thromres.2022.08.015_bb0085","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1378\/chest.09-1533","article-title":"Vena cava filter occlusion and venous thromboembolism risk in persistently anticoagulated patients: a prospective, observational cohort study","volume":"137","author":"Hajduk","year":"2010","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.thromres.2022.08.015_bb0090","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.jvir.2011.08.024","article-title":"Systematic review of the use of retrievable inferior vena cava filters","volume":"22","author":"Angel","year":"2011","journal-title":"J. Vasc. Interv. Radiol."},{"issue":"10","key":"10.1016\/j.thromres.2022.08.015_bb0095","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.jvir.2020.06.014","volume":"31","author":"Kaufman","year":"2020","journal-title":"J. Vasc. Interv. Radiol."},{"key":"10.1016\/j.thromres.2022.08.015_bb0100","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.thromres.2016.03.011","article-title":"Variability in management of hematologic malignancy patients with venous thromboembolism and chemotherapy-induced thrombocytopenia","volume":"141","author":"Samuelson","year":"2016","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.thromres.2022.08.015_bb0105","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11239-017-1539-4","article-title":"Patients treated for acute VTE during periods of treatment-related thrombocytopenia have high rates of recurrent thrombosis and transfusion-related adverse outcomes","volume":"44","author":"Samuelson Bannow","year":"2017","journal-title":"J. Thromb. Thrombolysis"},{"issue":"6","key":"10.1016\/j.thromres.2022.08.015_bb0110","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/jth.14015","article-title":"Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH","volume":"16","author":"Samuelson Bannow","year":"2018","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2022.08.015_bb0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3747\/co.22.2392","article-title":"Clinical challenges in patients with cancer-associated thrombosis: Canadian expert consensus recommendations","volume":"22","author":"Carrier","year":"2015","journal-title":"Curr. Oncol."},{"issue":"3","key":"10.1016\/j.thromres.2022.08.015_bb0120","first-page":"171","article-title":"Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus","volume":"17","author":"Napolitano","year":"2019","journal-title":"Blood Transfus."},{"issue":"10","key":"10.1016\/j.thromres.2022.08.015_bb0125","first-page":"1181","article-title":"Cancer-associated venous thromboembolic disease, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Streiff","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"6","key":"10.1016\/j.thromres.2022.08.015_bb0130","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1177\/1078155220957747","article-title":"Outcomes with enoxaparin dose reductions during thrombocytopenia in patients with hematopoietic stem cell transplantation (HSCT)","volume":"27","author":"Lam","year":"2020","journal-title":"J. Oncol. Pharm. Pract."},{"issue":"9","key":"10.1016\/j.thromres.2022.08.015_bb0135","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/ajh.26268","article-title":"Impact of anticoagulation on recurrent thrombosis and bleeding after hematopoietic cell transplantation","volume":"96","author":"Martens","year":"2021","journal-title":"Am. J. Hematol."},{"issue":"2","key":"10.1016\/j.thromres.2022.08.015_bb0140","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.blre.2014.10.002","article-title":"Is there a rationale for treatment of chronic liver disease with antithrombotic therapy?","volume":"29","author":"Hugenholtz","year":"2015","journal-title":"Blood Rev."},{"issue":"1","key":"10.1016\/j.thromres.2022.08.015_bb0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.maturitas.2013.02.009","article-title":"Risk factors for falls among older adults: a review of the literature","volume":"75","author":"Ambrose","year":"2013","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.thromres.2022.08.015_bb0150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.thromres.2022.08.015_bb0155","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1111\/j.1538-7836.2010.03986.x","article-title":"Venous thrombosis in the elderly: incidence, risk factors and risk groups","volume":"8","author":"Engbers","year":"2010","journal-title":"J. Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.thromres.2022.08.015_bb0160","first-page":"1046","article-title":"Venous thromboembolism in very elderly patients: findings from a prospective registry (RIETE)","volume":"91","author":"L\u00f3pez-Jim\u00e9nez","year":"2006","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.thromres.2022.08.015_bb0165","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archinte.159.7.677","article-title":"Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls","volume":"159","author":"Man-Son-Hing","year":"1999","journal-title":"Arch. Intern. Med."},{"issue":"8","key":"10.1016\/j.thromres.2022.08.015_bb0170","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s40266-021-00870-6","article-title":"Impact of fall risk and direct oral anticoagulant treatment on quality-adjusted life-years in older adults with atrial fibrillation: a Markov decision analysis","volume":"38","author":"Wei","year":"2021","journal-title":"Drugs Aging"},{"issue":"19","key":"10.1016\/j.thromres.2022.08.015_bb0175","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.thromres.2022.08.015_bb0180","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/blood-2015-12-635094","article-title":"How I treat patients with inherited bleeding disorders who need anticoagulant therapy","volume":"128","author":"Martin","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2022.08.015_bb0185","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11239-006-6556-7","article-title":"Non-catheter associated venous thrombosis in hemophiliaA and B. A critical review of all reported cases","volume":"21","author":"Girolami","year":"2006","journal-title":"J. Thromb. Thrombolysis"},{"issue":"1","key":"10.1016\/j.thromres.2022.08.015_bb0190","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/MBC.0000000000000179","article-title":"Venous thrombosis in von Willebrand disease as observed in one centre and as reported in the literature","volume":"26","author":"Girolami","year":"2015","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"1","key":"10.1016\/j.thromres.2022.08.015_bb0195","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.thromres.2014.11.010","article-title":"Incidence of symptomatic venous thromboembolism in patients with hemophilia undergoing joint replacement surgery: a retrospective study","volume":"135","author":"Perez Botero","year":"2015","journal-title":"Thromb. Res."},{"issue":"6","key":"10.1016\/j.thromres.2022.08.015_bb0200","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/hae.12189","article-title":"Applicability of the European Society of Cardiology guidelines on management of acute coronary syndromes to people with haemophilia - an assessment by the ADVANCE Working Group","volume":"19","author":"Staritz","year":"2013","journal-title":"Haemophilia"},{"issue":"20","key":"10.1016\/j.thromres.2022.08.015_bb0205","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1182\/blood-2016-07-727032","article-title":"New concepts for anticoagulant therapy in persons with hemophilia","volume":"128","author":"Schutgens","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2022.08.015_bb0210","first-page":"204","article-title":"Risk of bleeding on triple antithrombotic therapy after percutaneous coronary intervention\/stenting: a systematic review and meta-analysis","volume":"29","author":"Andrade","year":"2013","journal-title":"Can. J. Cardiol."},{"issue":"19","key":"10.1016\/j.thromres.2022.08.015_bb0215","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/eurheartj\/ehy162","article-title":"Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials","volume":"39","author":"Golwala","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2022.08.015_bb0220","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijcard.2018.07.133","article-title":"Antithrombotic therapy for patients with an indication for oral anticoagulation undergoing percutaneous coronary intervention with stent: the case of venous thromboembolism","volume":"269","author":"Riva","year":"2018","journal-title":"Int. J. Cardiol."},{"issue":"5","key":"10.1016\/j.thromres.2022.08.015_bb0225","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jacc.2020.09.011","volume":"77","author":"Kumbhani","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"22","key":"10.1016\/j.thromres.2022.08.015_bb0230","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1182\/bloodadvances.2018024893","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy","volume":"2","author":"Witt","year":"2018","journal-title":"Blood Adv."},{"issue":"5","key":"10.1016\/j.thromres.2022.08.015_bb0235","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/STROKEAHA.116.013343","article-title":"Anticoagulant-associated intracranial hemorrhage in the era of reversal agents","volume":"48","author":"Steiner","year":"2017","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.thromres.2022.08.015_bb0240","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/ene.13742","article-title":"Fatal oral anticoagulant-related intracranial hemorrhage: a systematic review and meta-analysis","volume":"25","author":"Katsanos","year":"2018","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.thromres.2022.08.015_bb0245","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/rth2.12377","article-title":"Anticoagulation after intracranial hemorrhage in brain tumors: risk of recurrent hemorrhage and venous thromboembolism","volume":"4","author":"Carney","year":"2020","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.thromres.2022.08.015_bb0250","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1111\/jth.15466","article-title":"Anticoagulant-associated gastrointestinal bleeding: framework for decisions about whether, when and how to resume anticoagulants","volume":"19","author":"Xu","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"9921","key":"10.1016\/j.thromres.2022.08.015_bb0255","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.thromres.2022.08.015_bb0260","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1001\/jama.2018.17242","article-title":"Association of oral anticoagulants and proton pump inhibitor cotherapy with hospitalization for upper gastrointestinal tract bleeding","volume":"320","author":"Ray","year":"2018","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.thromres.2022.08.015_bb0265","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1055\/a-1369-5274","article-title":"Endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage (NVUGIH): European Society of Gastrointestinal Endoscopy (ESGE) guideline - update 2021","volume":"53","author":"Gralnek","year":"2021","journal-title":"Endoscopy"},{"issue":"19","key":"10.1016\/j.thromres.2022.08.015_bb0270","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1001\/archinternmed.2012.4261","article-title":"Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding","volume":"172","author":"Witt","year":"2012","journal-title":"Arch. Intern. Med."},{"issue":"12","key":"10.1016\/j.thromres.2022.08.015_bb0275","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.cgh.2018.05.005","article-title":"Rebleeding vs thromboembolism after hospitalization for gastrointestinal bleeding in patients on direct oral anticoagulants","volume":"16","author":"Sengupta","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.thromres.2022.08.015_bb0280","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s10620-020-06248-9","article-title":"Resuming anticoagulation following hospitalization for gastrointestinal bleeding is associated with reduced thromboembolic events and improved mortality: results from a systematic review and meta-analysis","volume":"66","author":"Tapaskar","year":"2021","journal-title":"Dig. Dis. Sci."},{"issue":"6","key":"10.1016\/j.thromres.2022.08.015_bb0285","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/MCG.0000000000000821","article-title":"Resumption of warfarin after hospitalization for lower gastrointestinal bleeding and mortality benefits","volume":"52","author":"Patel","year":"2018","journal-title":"J. Clin. Gastroenterol."},{"issue":"2 Suppl","key":"10.1016\/j.thromres.2022.08.015_bb0290","doi-asserted-by":"crossref","first-page":"e152S","DOI":"10.1378\/chest.11-2295","article-title":"Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Holbrook","year":"2012","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.thromres.2022.08.015_bb0295","first-page":"100","article-title":"American College of Gastroenterology-Canadian Association of Gastroenterology clinical practice guideline: management of anticoagulants and antiplatelets during acute gastrointestinal bleeding and the periendoscopic period","volume":"5","author":"Abraham","year":"2022","journal-title":"Am. J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.thromres.2022.08.015_bb0300","doi-asserted-by":"crossref","first-page":"899","DOI":"10.14309\/ajg.0000000000001245","article-title":"ACG clinical guideline: upper gastrointestinal and ulcer bleeding","volume":"116","author":"Laine","year":"2021","journal-title":"Am. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.thromres.2022.08.015_bb0305","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/gutjnl-2017-315131","article-title":"Management of patients on antithrombotic agents undergoing emergency and elective endoscopy: joint Asian Pacific Association of Gastroenterology (APAGE) and Asian Pacific Society for Digestive Endoscopy (APSDE) practice guidelines","volume":"67","author":"Chan","year":"2018","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.thromres.2022.08.015_bb0310","first-page":"129","article-title":"Pulmonary embolism, part I: epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism","volume":"18","author":"B\u0115lohl\u00e1vek","year":"2013","journal-title":"Exp. Clin. Cardiol."},{"issue":"4","key":"10.1016\/j.thromres.2022.08.015_bb0315","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.athoracsur.2017.10.041","article-title":"Venous thromboembolism in patients hospitalized for lung transplantation","volume":"105","author":"Aboagye","year":"2018","journal-title":"Ann. Thorac. Surg."},{"issue":"4","key":"10.1016\/j.thromres.2022.08.015_bb0320","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.healun.2007.01.009","article-title":"High incidence of venous thromboembolic events in lung transplant recipients","volume":"26","author":"Kahan","year":"2007","journal-title":"J. Heart Lung Transplant"},{"issue":"10","key":"10.1016\/j.thromres.2022.08.015_bb0325","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.healun.2021.07.010","article-title":"Venous thromboembolism in lung transplant recipients real world experience from a high volume center","volume":"40","author":"Zheng","year":"2021","journal-title":"J. Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.thromres.2022.08.015_bb0330","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/TP.0000000000001977","article-title":"Venous thromboembolism after adult lung transplantation: a frequent event associated with lower survival","volume":"102","author":"Ribeiro Neto","year":"2018","journal-title":"Transplantation"},{"issue":"Suppl 1","key":"10.1016\/j.thromres.2022.08.015_bb0335","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thoraxjnl-2013-203618","article-title":"British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE","volume":"68","author":"Du Rand","year":"2013","journal-title":"Thorax"},{"issue":"Suppl 10","key":"10.1016\/j.thromres.2022.08.015_bb0340","doi-asserted-by":"crossref","first-page":"S1022","DOI":"10.21037\/jtd.2017.05.45","article-title":"Management of oral antiplatelet agents and anticoagulation therapy before bronchoscopy","volume":"9","author":"Youness","year":"2017","journal-title":"J. Thorac. Dis."},{"issue":"2","key":"10.1016\/j.thromres.2022.08.015_bb0345","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11926-014-0481-0","article-title":"The challenge of bleeding in antiphospholipid antibody-positive patients","volume":"17","author":"Pazzola","year":"2015","journal-title":"Curr. Rheumatol. Rep."},{"issue":"7","key":"10.1016\/j.thromres.2022.08.015_bb0350","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.autrev.2014.03.002","article-title":"14th international congress on antiphospholipid antibodies task force report on catastrophic antiphospholipid syndrome","volume":"13","author":"Cervera","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"9","key":"10.1016\/j.thromres.2022.08.015_bb0355","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11926-020-00935-2","article-title":"Management of non-criteria manifestations in antiphospholipid syndrome","volume":"22","author":"Xourgia","year":"2020","journal-title":"Curr. Rheumatol. Rep."},{"issue":"1","key":"10.1016\/j.thromres.2022.08.015_bb0360","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.suc.2013.10.007","article-title":"Retroperitoneal and rectus sheath hematomas","volume":"94","author":"Kasotakis","year":"2014","journal-title":"Surg. Clin. North Am."},{"issue":"2","key":"10.1016\/j.thromres.2022.08.015_bb0365","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/j.jemermed.2011.06.006","article-title":"Spontaneous retroperitoneal hematoma: etiology, characteristics, management, and outcome","volume":"43","author":"Sunga","year":"2012","journal-title":"J. Emerg. Med."},{"issue":"8","key":"10.1016\/j.thromres.2022.08.015_bb0370","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1007\/s00268-019-04988-y","article-title":"Spontaneous retroperitoneal and rectus sheath hemorrhage-management, risk factors and outcomes","volume":"43","author":"Baekgaard","year":"2019","journal-title":"World J. Surg."},{"issue":"5","key":"10.1016\/j.thromres.2022.08.015_bb0375","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/17474086.2020.1733963","article-title":"Clinical spectrum, risk factors, management and outcome of patients with retroperitoneal hematoma: a retrospective analysis of 3-year experience","volume":"13","author":"Sahu","year":"2020","journal-title":"Expert. Rev. Hematol."},{"key":"10.1016\/j.thromres.2022.08.015_bb0380","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1186\/1756-0500-7-586","article-title":"Rectus sheath hematoma with low molecular weight heparin administration: a case series","volume":"7","author":"Sullivan","year":"2014","journal-title":"BMC Res. Notes"},{"issue":"1","key":"10.1016\/j.thromres.2022.08.015_bb0385","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13256-022-03318-6","article-title":"Rectus sheath hematoma associated with commencement of therapeutic low molecular weight heparin injections: a case report","volume":"16","author":"Zhou","year":"2022","journal-title":"J. Med. Case Rep."},{"issue":"5","key":"10.1016\/j.thromres.2022.08.015_bb0390","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1182\/blood-2018-06-820746","article-title":"Treatment of bleeding complications in patients on anticoagulant therapy","volume":"133","author":"Piran","year":"2019","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.thromres.2022.08.015_bb0395","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1007\/s00268-013-2158-7","article-title":"Spontaneous rectus sheath hematomas: when to restart anticoagulation?","volume":"37","author":"Kunkala","year":"2013","journal-title":"World J. Surg."},{"issue":"7","key":"10.1016\/j.thromres.2022.08.015_bb0400","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.medcli.2015.04.033","article-title":"Clinical spectrum of patients with spontaneous retroperitoneal hematomas","volume":"145","author":"S\u00e1nchez-Gonz\u00e1lez","year":"2015","journal-title":"Med. Clin. (Barc.)"},{"issue":"6","key":"10.1016\/j.thromres.2022.08.015_bb0405","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/archinte.1994.00420060075008","article-title":"The significance of hematuria in the anticoagulated patient","volume":"154","author":"Culclasure","year":"1994","journal-title":"Arch. Intern. Med."},{"issue":"3","key":"10.1016\/j.thromres.2022.08.015_bb0410","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/jth.13229","article-title":"Anticoagulation-related nephropathy","volume":"14","author":"Wheeler","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.thromres.2022.08.015_bb0415","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1093\/ndt\/gft380","article-title":"Warfarin-related nephropathy is the tip of the iceberg: direct thrombin inhibitor dabigatran induces glomerular hemorrhage with acute kidney injury in rats","volume":"29","author":"Ryan","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4","key":"10.1016\/j.thromres.2022.08.015_bb0420","doi-asserted-by":"crossref","first-page":"387","DOI":"10.23876\/j.krcp.2017.36.4.387","article-title":"Acute kidney injury aggravated by treatment initiation with apixaban: another twist of anticoagulant-related nephropathy","volume":"36","author":"Brodsky","year":"2017","journal-title":"Kidney Res. Clin. Pract."},{"key":"10.1016\/j.thromres.2022.08.015_bb0425","article-title":"Anticoagulant related nephropathy induced by dabigatran","volume":"2018","author":"Sharfuddin","year":"2018","journal-title":"Case Rep. Nephrol."},{"issue":"12","key":"10.1016\/j.thromres.2022.08.015_bb0430","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1681\/ASN.2018070741","article-title":"Anticoagulant-related nephropathy","volume":"29","author":"Brodsky","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.thromres.2022.08.015_bb0435","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/203579","article-title":"Tranexamic acid treatment of life-threatening hematuria in polycystic kidney disease","volume":"2011","author":"Alameel","year":"2011","journal-title":"Int. J. Nephrol."},{"issue":"2","key":"10.1016\/j.thromres.2022.08.015_bb0440","first-page":"160","article-title":"Medical therapy with tranexamic acid in autosomal dominant polycystic kidney disease patients with severe haematuria","volume":"32","author":"Peces","year":"2012","journal-title":"Nefrologia"},{"key":"10.1016\/j.thromres.2022.08.015_bb0445","unstructured":". S.G. Lee et al, Systematic review of hematuria and acute renal failure with tranexamic acid. European Journal of Haematology. n\/a(n\/a)."},{"issue":"5","key":"10.1016\/j.thromres.2022.08.015_bb0450","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12570","article-title":"Menstruation, anticoagulation, and contraception: VTE and uterine bleeding","volume":"5","author":"Samuelson Bannow","year":"2021","journal-title":"Res. Pract.Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2022.08.015_bb0455","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.contraception.2010.12.011","article-title":"Menstrual problems and contraception in women of reproductive age receiving oral anticoagulation","volume":"84","author":"Huq","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.thromres.2022.08.015_bb0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2017.05.001","article-title":"Abnormal uterine bleeding in women receiving direct oral anticoagulants for the treatment of venous thromboembolism","volume":"93\u201395","author":"Godin","year":"2017","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.thromres.2022.08.015_bb0465","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.thromres.2020.11.014","article-title":"Heavy menstrual bleeding in women on oral anticoagulants","volume":"197","author":"Samuelson Bannow","year":"2021","journal-title":"Thromb. Res."},{"issue":"11","key":"10.1016\/j.thromres.2022.08.015_bb0470","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2015-08-665927","article-title":"Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use","volume":"127","author":"Martinelli","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2022.08.015_bb0475","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/AOG.0b013e3181f20177","article-title":"Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial","volume":"116","author":"Lukes","year":"2010","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.thromres.2022.08.015_bb0480","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1471-0528.2008.01926.x","article-title":"The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case-control study using the General Practice Research Database","volume":"116","author":"Sundstr\u00f6m","year":"2009","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.thromres.2022.08.015_bb0485","first-page":"714","article-title":"No increased risk of venous thrombosis in women taking tranexamic acid","volume":"86","author":"Berntorp","year":"2001","journal-title":"Thromb. Haemost."},{"issue":"24","key":"10.1016\/j.thromres.2022.08.015_bb0490","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1182\/blood-2017-07-797423","article-title":"How I treat heavy menstrual bleeding associated with anticoagulants","volume":"130","author":"Boonyawat","year":"2017","journal-title":"Blood"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384822003577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384822003577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:49:50Z","timestamp":1758736190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384822003577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":98,"alternative-id":["S0049384822003577"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2022.08.015","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenging clinical scenarios for therapeutic anticoagulation: A practical approach","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2022.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}